XL820 Completed Phase 1 Trials for Cancer Treatment
| Indications | Status | Purpose | Phase |
|---|---|---|---|
| Completed | Treatment | 1 |
| clinicaltrials.gov Identifier | Title | Drugs |
|---|---|---|
| NCT00350831 | Study of XL820 Given Orally Daily to Subjects With Solid Tumors | |
| NCT00129571 | Study of XL820 in Adults With Solid Tumors |